Human primary liver cancer–derived organoid cultures for disease modeling and drug screeningLaura Broutier, Meritxell Huch, Gianmarco Mastrogiovanni et al.|Nature Medicine|2017Cited by 1.5k
Tissue-resident Macrophages Protect the Liver From Ischemia Reperfusion Injury via a Heme Oxygenase-1-Dependent MechanismLuke Devey, Stephen J. Wigmore|Molecular Therapy|2008Cited by 136
<i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Alison Meynert et al.|Cancer Research|2022Cited by 17
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target CholangiocarcinomaNicholas T. Younger, Luke Boulter, Mollie L. Wilson et al.|Unknown|2023Cited by 0